Kozel T R, Wilson M A, Pfrommer G S, Schlageter A M
Department of Microbiology, University of Nevada-Reno 89557.
Infect Immun. 1989 Jul;57(7):1922-7. doi: 10.1128/iai.57.7.1922-1927.1989.
Encapsulated Cryptococcus neoformans yeast cells are potent activators of the complement system. We examined the interaction of the yeast cells with an alternative complement pathway reconstituted from isolated factor D, factor B, factor H, factor I, C3, and properdin. Incubation of encapsulated cryptococci with the reconstituted pathway led to activation and binding of C3 fragments to the yeast cells that was quantitatively and qualitatively identical to that observed with normal human serum. Incubation with either normal serum or a mixture of isolated proteins led to binding of 4 x 10(7) to 5 x 10(7) C3 molecules to the yeast cells. The kinetics for activation and binding of C3 were identical, with maximum binding observed after a 20-min incubation. Immunoglobulin G was not needed for optimal activation kinetics. C3 fragments eluted from the yeast cells by treatment with hydroxylamine and subsequent analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated the presence primarily of iC3b on yeast cells incubated with either normal serum or the reconstituted pathway. Ultrastructural examination of the opsonized yeast cells showed that the cryptococcal capsule was the site for binding of C3 activated from normal serum or the reconstituted pathway, with a dense accumulation of C3 at the periphery of the capsule. Thus, incubation of encapsulated cryptococci in the reconstituted pathway led to deposition of opsonic complement fragments at a site that was appropriate for interaction with phagocyte receptors. Cryptococci opsonized with the reconstituted pathway showed a markedly enhanced interaction with cultured human monocytes compared with unopsonized yeast cells, indicating that the alternative pathway alone is opsonic for yeast cells. However, the results indicate that additional serum factors are needed for optimal opsonization of yeast cells because a 35% reduction in the number of cryptococci bound to macrophages was observed with cryptococci opsonized with the reconstituted pathway compared with that observed when yeast cells were opsonized with normal serum.
被包裹的新型隐球菌酵母细胞是补体系统的强效激活剂。我们研究了酵母细胞与由分离的D因子、B因子、H因子、I因子、C3和备解素重构的替代补体途径之间的相互作用。将被包裹的隐球菌与重构途径一起孵育导致C3片段激活并结合到酵母细胞上,这在数量和质量上与正常人血清观察到的情况相同。用正常血清或分离蛋白混合物孵育导致4×10⁷至5×10⁷个C3分子结合到酵母细胞上。C3激活和结合的动力学相同,孵育20分钟后观察到最大结合。最佳激活动力学不需要免疫球蛋白G。用羟胺处理从酵母细胞上洗脱C3片段,随后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析表明,在用正常血清或重构途径孵育的酵母细胞上主要存在iC3b。对调理后的酵母细胞进行超微结构检查表明,隐球菌荚膜是从正常血清或重构途径激活的C3的结合位点,在荚膜周边有密集的C3聚集。因此,将被包裹的隐球菌在重构途径中孵育导致调理素补体片段沉积在适合与吞噬细胞受体相互作用的位点。与未调理的酵母细胞相比,用重构途径调理的隐球菌与培养的人单核细胞的相互作用明显增强,表明单独的替代途径对酵母细胞具有调理作用。然而,结果表明酵母细胞的最佳调理需要额外的血清因子,因为与用正常血清调理酵母细胞时相比,用重构途径调理的隐球菌与巨噬细胞结合的数量减少了35%。